Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Camber Capital Takes Big Position in Med-Tech Company Biolase

Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ:BIOL). In a filing with the Securities and Exchange Commission, Stephen Dubois’ fund disclosed ownership of slightly below 2.7 million shares, which have a value of $5.4 million. The new position represents around 7.3% of Biolase.

Disclosure: none